热门资讯> 正文

Reviva Pharmaceuticals宣布公开募股;股价下跌近15%

2025-06-26 04:28

Reviva Pharmaceuticals (NASDAQ:RVPH) plans to offer common stock or equivalents and warrants in a public offering.
All securities in the offering will be sold by the company.
Proceeds will support R&D efforts, working capital, and general corporate purposes.
RVPH shares fall nearly 15% post-market on Wednesday.
Source: Press release

More on Reviva Pharmaceuticals

Seeking Alpha’s Quant Rating on Reviva Pharmaceuticals
Historical earnings data for Reviva Pharmaceuticals
Financial information for Reviva Pharmaceuticals

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。